SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-169395
Filing Date
2022-06-07
Accepted
2022-06-07 17:30:36
Documents
18
Period of Report
2022-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d286083d8k.htm   iXBRL 8-K 28006
2 EX-99.1 d286083dex991.htm EX-99.1 25902
7 GRAPHIC g286083adsp001.jpg GRAPHIC 10889
8 GRAPHIC g286083dsp001.jpg GRAPHIC 10889
9 GRAPHIC g286083dsp001a.jpg GRAPHIC 13126
10 GRAPHIC g286083dsp002.jpg GRAPHIC 7041
  Complete submission text file 0001193125-22-169395.txt   275415

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20220607.xsd EX-101.SCH 3940
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20220607_def.xml EX-101.DEF 13310
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20220607_lab.xml EX-101.LAB 21931
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20220607_pre.xml EX-101.PRE 14207
12 EXTRACTED XBRL INSTANCE DOCUMENT d286083d8k_htm.xml XML 5630
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221002070
SIC: 2836 Biological Products, (No Diagnostic Substances)